Andrew Cooper (Raymond James) — Analyst Ratings, Accuracy & Track Record

Q: How accurate are Andrew Cooper's stock ratings?

About 42% of Andrew's ratings were profitable over a one-year hold, with an average return of -7.2% per rating, measured by 13Foresight from historical prices.

Q: How is Andrew ranked?

Andrew Cooper is ranked #2123 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Analyst Tracker/Andrew Cooper

Andrew Cooper

Raymond James

Wall Street Analyst

★★☆☆☆

#2123

on 13Foresight · ranked by our own returns

42%

Success Rate

-7.3%

Average Return

8 of 19 calls profitable · -23.1% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compare To ⓘ

📈 Across the calls we could measure, roughly 42% of Andrew Cooper's ratings turned a profit when each position was held for 1 year — averaging -7.3% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

20 Buy 4 Hold 0 Sell

Andrew's Stock Coverage 21 ratings · 2026-06-20

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return
GH Guardant Health	Feb 23, 2026	BUY	Strong Buy -5.9% avg upside 30 analysts	$129.00 2.09% Downside	+36.7%
ITGR Integer Holdings	Feb 23, 2026	BUY	Buy +6.0% avg upside 15 analysts	$101.00 11.09% Upside	+5.5%
MYGN Myriad Genetics	Jan 13, 2026	BUY	Hold +313.3% avg upside 24 analysts	$8.00 76.31% Upside	-36.9%
AZTA Azenta	Nov 25, 2025	BUY	Buy +101.3% avg upside 13 analysts	$45.00 92.97% Upside	-40.5%
AVTR Avantor	Nov 04, 2025	HOLD	Buy +49.6% avg upside 26 analysts	—	-18.3%
RVTY Revvity	Oct 28, 2025	BUY	Buy +5.2% avg upside 23 analysts	$115.00 15.07% Upside	+1.6%
HAE Haemonetics	Aug 11, 2025	BUY	Buy -9.2% avg upside 17 analysts	$78.00 5.16% Upside	+11.5%
QDEL QuidelOrtho	Aug 06, 2025	BUY	Buy +183.5% avg upside 13 analysts	$55.00 302.42% Upside	-44.0%
FLGT Fulgent Genetics	Aug 04, 2025	BUY	Buy +142.6% avg upside 7 analysts	$25.00 38.90% Upside	-13.9%
TMO Thermo Fisher	Jul 24, 2025	BUY	Strong Buy +26.8% avg upside 38 analysts	$535.00 15.22% Upside	-2.5%
DHR Danaher	Jul 23, 2025	HOLD	Strong Buy +21.9% avg upside 45 analysts	—	-9.7%
UFPT Ufp Technologies	Mar 28, 2025	HOLD	Strong Buy -20.8% avg upside 7 analysts	—	-5.0%
NEO NeoGenomics	Feb 18, 2025	HOLD	Strong Buy +37.2% avg upside 17 analysts	—	-17.3%
NTRA Natera	Feb 10, 2025	BUY	Strong Buy +7.4% avg upside 26 analysts	$175.00 24.39% Downside	+22.9%
CDNA CareDx	May 13, 2024	HOLD	Buy +25.1% avg upside 16 analysts	—	+7.7%
CTKB Cytek Biosciences	Jul 18, 2023	HOLD	Buy +50.8% avg upside 5 analysts	—	-29.1%
VCYT Veracyte	Feb 22, 2023	HOLD	Strong Buy -20.7% avg upside 17 analysts	—	+1.8%
OSUR Orasure Technologies	Feb 15, 2023	HOLD	Buy +100.0% avg upside 11 analysts	—	·
BIORQ Biora Therapeutics	Feb 24, 2022	BUY	Strong Buy +269249900.0% avg upside 6 analysts	$1050.00 1049999899.94% Upside	·
TRUP Trupanion	Feb 11, 2021	HOLD	Strong Buy +73.6% avg upside 19 analysts	—	-14.9%
IDXX Idexx Laboratories	Feb 02, 2021	HOLD	Buy +29.2% avg upside 17 analysts	—	+5.4%

🔒 16 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Andrew Cooper — Frequently Asked Questions

How accurate are Andrew Cooper's stock ratings?

Based on the calls 13Foresight could measure, about 42% of Andrew's ratings were profitable over a one-year hold, with an average return of -7.2% per rating, or -23.0% versus the S&P 500. We score every analyst the same way, from historical prices.

How is Andrew ranked on 13Foresight?

Andrew Cooper is currently ranked #2123 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Andrew cover?

Andrew most recently has ratings on GH, ITGR, MYGN, AZTA, AVTR, RVTY, HAE, QDEL, FLGT, TMO, DHR, UFPT and 9 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Rating Distribution

Welcome to 13Foresight!